David Guzo

Array ( [id] => 1601770 [patent_doc_number] => 06476188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Clock gene and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/553867 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 61 [patent_no_of_words] => 64654 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476188.pdf [firstpage_image] =>[orig_patent_app_number] => 09553867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1299088 [patent_doc_number] => 06623940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell' [patent_app_type] => B1 [patent_app_number] => 09/549067 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 23 [patent_no_of_words] => 19214 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623940.pdf [firstpage_image] =>[orig_patent_app_number] => 09549067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473129 [patent_doc_number] => 06387368 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Hybrid adenovirus-AAV virus and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/546738 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 13500 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387368.pdf [firstpage_image] =>[orig_patent_app_number] => 09546738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4270100 [patent_doc_number] => 06323024 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products' [patent_app_type] => 1 [patent_app_number] => 9/403672 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8923 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323024.pdf [firstpage_image] =>[orig_patent_app_number] => 403672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1573804 [patent_doc_number] => 06468524 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'AAV4 vector and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/532594 [patent_app_country] => US [patent_app_date] => 2000-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 27118 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468524.pdf [firstpage_image] =>[orig_patent_app_number] => 09532594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4301973 [patent_doc_number] => 06326150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Yeast interaction trap assay' [patent_app_type] => 1 [patent_app_number] => 9/508803 [patent_app_country] => US [patent_app_date] => 2000-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 11174 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326150.pdf [firstpage_image] =>[orig_patent_app_number] => 508803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4322953 [patent_doc_number] => 06329137 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses' [patent_app_type] => 1 [patent_app_number] => 9/519773 [patent_app_country] => US [patent_app_date] => 2000-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 7356 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329137.pdf [firstpage_image] =>[orig_patent_app_number] => 519773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4270236 [patent_doc_number] => 06323031 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-27 [patent_title] => 'Lentiviral vectors derived from SIVagm, methods for their preparation and their use for gene transfer into mammalian cells' [patent_app_type] => 1 [patent_app_number] => 9/517921 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2270 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/323/06323031.pdf [firstpage_image] =>[orig_patent_app_number] => 517921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 823365 [patent_doc_number] => 07405038 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-29 [patent_title] => 'Stable cell lines resistant to apoptosis and nutrient stress and methods of making same' [patent_app_type] => utility [patent_app_number] => 09/518763 [patent_app_country] => US [patent_app_date] => 2000-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8349 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405038.pdf [firstpage_image] =>[orig_patent_app_number] => 09518763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 689883 [patent_doc_number] => 07074400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-07-11 [patent_title] => 'Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene' [patent_app_type] => utility [patent_app_number] => 09/914651 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 10106 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074400.pdf [firstpage_image] =>[orig_patent_app_number] => 09914651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1483736 [patent_doc_number] => 06365127 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-02 [patent_title] => 'Isolation of a gene encoding human thyrotropin beta subunit' [patent_app_type] => B1 [patent_app_number] => 09/516352 [patent_app_country] => US [patent_app_date] => 2000-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2503 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/365/06365127.pdf [firstpage_image] =>[orig_patent_app_number] => 09516352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372452 [patent_doc_number] => 06303116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Genetically engineered retroviral vector particles capable of infecting non-dividing cells' [patent_app_type] => 1 [patent_app_number] => 9/496379 [patent_app_country] => US [patent_app_date] => 2000-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9916 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303116.pdf [firstpage_image] =>[orig_patent_app_number] => 496379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1353669 [patent_doc_number] => 06576463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => 'Hybrid vectors for gene therapy' [patent_app_type] => B1 [patent_app_number] => 09/484901 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 13951 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576463.pdf [firstpage_image] =>[orig_patent_app_number] => 09484901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4335769 [patent_doc_number] => 06333195 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Crossless retroviral vectors' [patent_app_type] => 1 [patent_app_number] => 9/479776 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 28 [patent_no_of_words] => 27486 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333195.pdf [firstpage_image] =>[orig_patent_app_number] => 479776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4351598 [patent_doc_number] => 06218105 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'High throughput papilloma virus in vitro infectivity assay' [patent_app_type] => 1 [patent_app_number] => 9/479825 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4659 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218105.pdf [firstpage_image] =>[orig_patent_app_number] => 479825 [rel_patent_id] =>[rel_patent_doc_number] =>)